Feature Stories
Updates every hour. Last Updated: 23-Oct-2025 15:11 ET (23-Oct-2025 19:11 GMT/UTC)
New targeted therapy, ulixertinib, shows promise for histiocytosis, a rare blood cancer
Memorial Sloan Kettering Cancer Center- Journal
- Cancer Cell
JMIR Publications Reports: Insights from the DCI Network's Recent Conference on Health Care AI
JMIR Publications- Journal
- Journal of Medical Internet Research
Q&A: How does processed fiber impact human health?
Penn State5 things everyone with Medicare should do right now
Michigan Medicine - University of Michigan- Journal
- Journal of the American Geriatrics Society
Are we counting the wrong people? Data gaps reveal GP visit numbers skewed by 20%
University of South AustraliaNew research from the University of South Australia shows that the way we count our population could distort how health services are planned and funded – with some regions potentially over- or under-invested by more than 20%.New research from the University of South Australia shows that the way we count our population could distort how health services are planned and funded – with some regions potentially over- or under-invested by more than 20%.
- Journal
- Health Promotion Journal of Australia
Can grape seed extract slow the growth of prostate cancer after treatment?
University of Colorado School of Medicine- Meeting
- AACR Annual Meeting 2025
Many patients learn they could have cancer in the emergency department
University of Colorado School of MedicineAbdominal and chest pain. Injuries. Breathing difficulty. Infections. Mental health emergencies. Those are some of the most common reasons why people go to the local emergency room. But that's also where a surprisingly large percentage of cancer cases are first diagnosed.
An understudied type of breast cancer poses a lurking threat
University of Colorado School of MedicineUniversity of Colorado Cancer Center member Matthew Sikora, PhD, is a national leader in research into an understudied subtype of breast cancer that’s on the rise in American women, is often more difficult to detect than other forms of breast cancer, and has sharply lower survival rates several years after diagnosis than the most common type of breast cancer. Sikora’s latest research seeks ways to open up a new treatment option for people with this challenging cancer type, known as lobular breast cancer or invasive lobular carcinoma (ILC), representing about 15% of all breast cancer cases.